Health & Environmental Research Online (HERO)


Print Feedback Export to File
3858490 
Journal Article 
Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells 
Zhou, X; Dong, T; Fan, Z; Peng, Y; Zhou, R; Wang, X; Song, N; Han, M; Fan, B; Jia, J; Liu, S 
2017 
Scientific Reports
EISSN: 2045-2322 
NATURE PUBLISHING GROUP 
LONDON 
45468 
English 
Perfluorodecanoic acid (PFDA), a perfluorinated carboxylic acid, presents in the environment and accumulates in human blood and organs, but its association with tumor promotion are not clear. Given that inflammation plays a significant role in the development of gastric malignancies, we evaluated the effects of PFDA on activation of the inflammasome and inflammation regulation in the gastric cell line AGS. When added to cell cultures, PFDA significantly stimulated IL-1β and IL18 secretion and their mRNA levels compared with control cells. By RT-PCR and western-blot we found that up-regulation of NLRP3 were associated with promotion of IL-1β and IL-18 production. Then expression variation of cIAP1/2, c-Rel and p52 were analyzed, the results demonstrated raised mRNA expression in all the tested genes concomitant with enhanced inflammasome activity after exposure to PFDA. Assays with cIAP2 siRNA and NFκB reporter provided additional evidence that these genes were involved in PFDA-induced inflammasome assembly. Furthermore, increased secretion of IL-1β and IL-18 were detected in stomach of PFDA-treated mice, disorganized alignment of epithelial cells and inflammatory cell infiltration were also observed in the stomach tissues upon PFDA treatment. This study reports for the first time that PFDA regulates inflammasome assembly in human cells and mice tissues. 
IRIS
• SR Automation
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          Other Sources
               TEDX
     Screened Studies
          Excluded
               Exclude (TIAB)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          Other Sources
               PFAS TOX Database
     Screened Studies
          Excluded
               Exclude (TIAB)
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               WOS
     PFDA (335-76-2)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search Update December 2020
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               PFAS TOX Database
     Not prioritized for screening
     Perfluorodecanoic acid
     Perfluorooctanesulfonate
     Perfluorooctanesulfonic acid
• PFDA
     Literature Search
          Pubmed
          WOS
     Scopus: April 2021
     Screening Results
          In vitro/ex vivo/in silico
               Immunotox mech
     Title and Abstract Screening
          Full Text Screening
               Studies Meeting PECO
                    Animal health effect studies
          Tagged as Supplemental
               Mechanistic or MOA
     June 2022 Pelch Database
     Literature Searches (through April 2023 update and post-public comment/peer review)a    
          Other
               Published PFAS SEMs
          Title & Abstract Screening
               Tagged as Supplemental
                    Full Text Screening
                    In vivo MOA, including non-PECO exposure route
• PFHxS
• PFNA
     Litsearch Update 2017-2018
          Pubmed
     Literature Search
          Pubmed
     Title and Abstract Screening
          Full Text Screening
               Excluded
                    Not PFNA
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          WOS
     Screening Results
          In vivo animal studies
               Immunotox
          In vitro/ex vivo/in silico
               Immunotox mech
     Literature Search Update (2013-2019)
          WOS